Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-23-000069

Chief Medical Officer returned 3,047 shares (to the company)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Nuyten Dimitry SA · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-18 Returned to the company : show line 1 in the form 10b5-1 −1,507 $17.74 $26,734 72,735 D
2023-12-19 Returned to the company : show line 2 in the form 10b5-1 −1,540 $18.09 $27,859 71,195 D
Loading xslF345X05/wk-form4_1703106628.xml…